Bionano Genomics Inc (NASDAQ:BNGO) shares have been sliding again for the past six weeks. After BNGO stock treaded water through much of the summer, investors were hoping for movement. Not downward, ...
First large study in constitutional genetic diseases showed 100% concordance to all gold-standard cytogenetic testing methods combined Demonstrates Bionano’s continued progress on goal of Saphyr ...
SAN DIEGO, Oct. 16, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets the Saphyr® system, a genome imaging platform for ...
SAN DIEGO, March 03, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that Praxis Genomics, LLC received DEX Z-codes from Palmetto MolDX for its entire testing menu of ...
As Cathie Wood and many others know, owning growth stocks over the last year has not been easy. Amid fears about inflation and rising interest rates, many such equities have tumbled. Famously, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results